Bank of Montreal
NYMX

Bank of Montreal’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bank of Montreal’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,500
Closed -$11K – 5173
2020
Q3 		$11K Buy
+4,500
New +$13.1K ﹤0.01% 4109
2019
Q2 		– Sell
-12,500
Closed -$25K – 5135
2019
Q1 		$25K Sell
12,500
-6,900
-36% -$14.6K ﹤0.01% 3597
2018
Q4 		$25K Buy
19,400
+13,700
+240% +$25.1K ﹤0.01% 3568
2018
Q3 		$14K Sell
5,700
-99,800
-95% -$295K ﹤0.01% 3829
2018
Q2 		$354K Buy
105,500
+37,000
+54% +$142K ﹤0.01% 2502
2018
Q1 		$290K Buy
68,500
+61,500
+879% +$213K ﹤0.01% 2461
2017
Q4 		$23K Buy
7,000
+1,000
+17% +$3.65K ﹤0.01% 3550
2017
Q3 		$23K Sell
6,000
-4,000
-40% -$15.2K ﹤0.01% 3482
2017
Q2 		$44K Buy
+10,000
New +$41.1K ﹤0.01% 3274

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Bank of Montreal's NYMX Position: Q2 2021 in Review

Bank of Montreal sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 1,939 shares — an estimated $5K sold.

Bank of Montreal first reported a position in NYMX in Q2 2013 and held it in 32 quarters. The position peaked at $356K in Q2 2018. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Bank of Montreal reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,939 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 32 quarters.
  • Bank of Montreal's Nymox Pharmaceutical Corp position peaked at $356K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.